ASO Visual Abstract: Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer-A Pilot Study

被引:1
|
作者
Khan, Sonia Y. [1 ]
Melkus, Michael W. [1 ]
Rasha, Fahmida [2 ]
Castro, Maribel [1 ]
Chu, Victoria [1 ]
Brandi, Luis [3 ]
Khan, Hafiz [4 ]
Gill, Harvinder Singh [5 ]
Pruitt, Kevin [2 ]
Rahman, Rakhshanda Layeequr [1 ,6 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Surg, Lubbock, TX 79430 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pathol, Lubbock, TX 79430 USA
[4] Texas Tech Univ, Hlth Sci Ctr, Julia Jones Matthews Dept Publ Hlth, Lubbock, TX 79430 USA
[5] Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA
[6] Texas Tech Univ, Hlth Sci Ctr, Breast Ctr Excellence, Lubbock, TX 79430 USA
关键词
D O I
10.1245/s10434-021-11240-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer is gaining momentum as an immunological biomarker. This experiment evaluates the role of TILs in distant tumors as a measure of abscopal effect from cryoablation of breast cancer. Methods: BALB/c mice underwent bilateral orthotopic transplant with 4T1-12B (triple-negative) cells. At 2 weeks, left tumors were treated by either resection (standard of care group) or cryoablation (intervention group) followed by resection of the distant right tumors 1 week posttreatment. TIL scores were calculated from hematoxylin and eosin-stained sections and phenotyped for cytotoxic T-lymphocyte (CTL) markers by immunofluorescence. Primarily resected tumors served as baseline (Tbaseline), whereas resected distant right-sided served as the readout for abscopal effect (AbsRes or AbsCryo). Mice were monitored for tumor recurrence and metastasis. Results: The AbsCryo had a significant mean (SD) increase in stromal (2.8 [1.1]%; p = 0.015) and invasive margin TILs (50 [12]%; p = 0.02) compared with TBaseline (1.0 [0]% and 31 [4.9]%, respectively). CTL phenotyping revealed a significant increase in mean (SD) CD8+ T cells (15.7 [12.1]; p = 0.02) and granzyme B (4.8 [3.6]; p = 0.048) for the AbsCryo compared with TBaseline (5.2 [4.7] and 2.4 [0.9], respectively). Posttreatment, the cryoablation group had no recurrence or metastasis, whereas the resected group showed local recurrence and lung metastasis in 40% of the mice. Postprocedure increase in TIL score of distant tumors was associated with decrease in tumor relapse (p = 0.02). Conclusions: Cryoablation induced a robust tumor-specific TIL response compared with resection, suggesting an abscopal effect leading to the prevention of cancer recurrence and metastasis. © 2022, The Author(s).
引用
收藏
页码:2928 / 2929
页数:2
相关论文
共 50 条
  • [41] Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group
    Swisher, Shannon K.
    Wu, Yun
    Castaneda, Carlos A.
    Lyons, Genvieve R.
    Yang, Fei
    Tapia, Coya
    Wang, Xiuhong
    Casavilca, Sandro A. A.
    Bassett, Roland
    Castillo, Miluska
    Sahin, Aysegul
    Mittendorf, Elizabeth A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (07) : 2242 - 2248
  • [42] Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy
    Okcu, Oguzhan
    Ozturk, Seda Duman
    Ozturk, Cigdem
    Sen, Bayram
    Yasin, Ayse Irem
    Bedir, Recep
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 58
  • [43] Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB)
    Asano, Y.
    Kashiwagi, S.
    Goto, W.
    Takada, K.
    Takashima, T.
    Morisaki, T.
    Noda, S.
    Onoda, N.
    Ohsawa, M.
    Hirakawa, K.
    Ohira, M.
    CANCER RESEARCH, 2017, 77
  • [44] Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice
    de Melo Gagliato, Debora
    Cortes, Javier
    Curigliano, Giuseppe
    Loi, Sherene
    Denkert, Carsten
    Perez-Garcia, Jose
    Holgado, Esther
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2017, 1868 (02): : 527 - 537
  • [45] Tumor-infiltrating lymphocytes predict prognosis in early breast cancer
    Mao, Y.
    Qu, Q.
    Wu, J.
    Chen, X.
    Huang, O.
    Shen, K.
    BREAST, 2015, 24 : S101 - S101
  • [46] Tumor-Infiltrating Lymphocytes in Breast Cancer: Ready for Prime Time?
    Ocana, Alberto
    Diez-Gonzalez, Laura
    Adrover, Encarna
    Fernandez-Aramburo, Antonio
    Pandiella, Atanasio
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1298 - +
  • [47] Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
    Loi, Sherene
    ONCOIMMUNOLOGY, 2013, 2 (07)
  • [48] Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer
    Kwa M.
    Adams S.
    Current Breast Cancer Reports, 2016, 8 (1) : 1 - 13
  • [49] Tumor-infiltrating lymphocytes/macrophages and clinical outcome in breast cancer
    Kim, Y-S.
    Kim, J-S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Diagnostic and Therapeutic Implications of Tumor-Infiltrating Lymphocytes in Breast Cancer
    Denkert, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 836 - 837